Comments
TPG to buy generic drugmaker Par for $1.9 billion
17.07.2012. | (Reuters) - Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion, the latest acquisition in the generic drug industry....
